Sort:  

🧵 3. Valiant Labs shares' GMP rose 14.29% before listing. Shareholders advised to book profits, but long-term holders can set stop loss at Rs 150.

🧵 5. Valiant Labs IPO receives Rs 45.74 Crore from anchor investors ahead of public issue. Minimum lot size is 105 shares, retail investment at Rs 14,700.

🧵 4. Valiant Labs is an API and Bulk Drug manufacturer specializing in Paracetamol. Sustained revenue growth of 35.3% during FY21-23.

🧵 2. Valiant Labs IPO subscribed 29.76 times, indicating positive response from investors. Consider company's risks before investing.